Adverse Event Management
Pain, Stigma, and Other Gynecologic Cancer Issues
BY DON S. DIZON, MD, FACP
FDA Grants ALPN-101 Orphan Drug Designations for GVHD Prevention, Treatment
BY JASON M. BRODERICK
Cancer Pain Management: Expert Talks Barriers, Management Strategies
BY BRIELLE BENYON
Expert Discusses Advances, Unmet Needs in GVHD Treatment
BY BRIELLE BENYON
ONN's Top 5 Stories: January 2020
BY JESSICA SKARZYNSKI
Dermatologic Adverse Events in Melanoma: What to Look Out For
BY BRITTANY COTE
Ovarian Suppression Plus AI Treatment Can Have Major Adverse Events
BY DAWN L. HERSHMAN, MD, MS
Nurse Offers Advice on Discussing AEs With Patients
BY KATHLEEN MADDEN, MSN, RN, APHN, AOCNP, FNP-BC
Managing irAEs is a Dynamic Discussion
BY BRIELLE BENYON AND GINA COLUMBUS
Luspatercept Reduces Anemia in Patients With MDS
BY BRITTANY COTE
External Resources
MJH Associates
American Journal of Managed Care
Cure
MD Magazine
Pharmacy Times
Physicians' Education Resource
Specialty Pharmacy Times
TargetedOnc
MJH Associates
American Journal of Managed Care
Cure
MD Magazine
Pharmacy Times
Physicians' Education Resource
Specialty Pharmacy Times
TargetedOnc
Intellisphere, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747
Copyright OncNursing 2006-2019
Intellisphere, LLC. All Rights Reserved.
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747
Copyright OncNursing 2006-2019
Intellisphere, LLC. All Rights Reserved.